ZYXI I bought some. Forward PE around 4 or less. Good insider positions. Good recurring revenue. Revenue growth close to 40%. Bad balance sheet though. Catalysts would be continued strong earnings and revenue growth, a debt refinancing, or their blood testing device being approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.